Urgent! Stop FDA Approval of Pfizer Shots for Kids 6 Months to 4 Years

 

This announcement came out Jan. 31 and it is so horrifying. It took me several minutes to come to grips with what is happening. I know the U.S. Food and Drug Administration (FDA) is evil but this takes things to another level.Pfizer wants its disastrous mRNA shot added to the official schedule for children so that the vaccine maker can have liability protection forever.The Pfizer mRNA shot in children 2 to 4 years old failed in the clinical trial. But, acting FDA Commissioner Dr. Janet Woodcock, likely following orders from the Biden administration, askedPfizer to submit an application anyway.

So on Feb. 1, Pfizer submitted an Emergency Use Authorization (EUA) application for children 6 months to 4 years old.

Pfizer and the FDA are proposing to start with two shots in this age group even though that approach has already failed and then they will add a third dose later in the spring if data comes in that supports that use.

The plan is literally — shoot up kids first, get the data later.

This approach is completely unprecedented in the history of the FDA and it must be stopped.

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in two weeks — on Feb. 15 — to evaluate this EUA application for a product that failed the clinical trial.

That’s what we are up against.

So warriors, you know what to do. I need you to get on the phone, get your fax machines humming, and start sending out emails like the future of this country depends on it — because it does.

Physical paper letters sent in the next couple days via the U.S. Postal Service will probably get there in time, too.

In October we generated tens of thousands of calls, emails, and faxes. Our goal in the next two weeks must be to generate hundreds of thousands of calls, emails, faxes, and letters.

The message we need to send to these bureaucrats is — ABSOLUTELY NOT! Every single person who plays a role in this decision needs to get the message that:

1. We are watching.
2. The clinical trial of the Pfizer vaccine failed in this age group.
3. You must vote NO because this proposed use violates the prohibitions against illegal medical experiments as outlined in the Nuremberg Code.

It’s hard to know exactly who will be at the FDA’s VRBPAC meeting because the FDA uses Temporary Voting Members and the VRBPAC has not met since we exposed them as frauds back in October (when they rubber stamped Pfizer’s EUA application for kids 5 to 11 — in spite of no data showing clinical effectiveness).

But the best guess is that the voting members will be roughly the same as the last meeting so that is who we are reaching out to now.

Here are the 23 people we need to reach before Feb. 15. Please be respectful and courteous.

Janet Woodcock
Acting FDA Commissioner
FDA, mail stop: HFD-001
10903 New Hampshire Ave., WO51-6133
Silver Spring MD 20993-0002
phone: (301) 796-5400
fax: (301) 847-8752
Janet.Woodcock@fda.hhs.gov
@DrWoodcockFDA

Rochelle Walensky
Director, Centers for Disease Control and Prevention
Roybal Building 21, Rm 12000
1600 Clifton Rd
Atlanta, GA 30333
phone: (404) 639-7000
Aux7@cdc.gov
https://twitter.com/CDCDirector

Xavier Becerra
Secretary, Health & Human Services
200 Independence Avenue S.W.
Washington, D.C. 20201
c/o Sean McCluskie
sean.mccluskie@hhs.gov
https://twitter.com/XavierBecerra

Peter Marks
Director, Center for Biologics Evaluation and Research
FDA, Mail stop: HFM-2
10903 New Hampshire Ave., WO71-7232
Silver Spring MD 20993-0002
phone: (240) 402-8116
fax: (301) 595-1310
Peter.Marks@fda.hhs.gov

Arnold Monto, M.D.
Acting Chair, VRBPAC
Professor of Public Health & Epidemiology
Department of Epidemiology
University of Michigan School of Public Health
Ann Arbor, MI 48109
phone: (734) 764-5453
fax: (734) 764-3192
asmonto@umich.edu

Paula Annunziato, M.D.
Vice President and Therapeutic Area Head
Vaccines Clinical Research at Merck
North Wales, PA 19454
paula.annunziato@merck.com

Captain Amanda Cohn
Chief Medical Officer
National Center for Immunizations and Respiratory Diseases
Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 MS C-09
phone: (404) 639-6039
fax: (404) 315-4679
acohn@cdc.gov
anc0@cdc.gov

The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children’s Health Defense.